Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 8,479 shares of the company's stock, valued at approximately $1,421,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank bought a new stake in Procter & Gamble during the fourth quarter valued at about $5,244,463,000. Raymond James Financial Inc. bought a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $1,010,685,000. Bank Julius Baer & Co. Ltd Zurich increased its holdings in Procter & Gamble by 1,195.1% in the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company's stock worth $580,596,000 after acquiring an additional 2,973,757 shares in the last quarter. Capital Research Global Investors lifted its holdings in Procter & Gamble by 62.5% during the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock valued at $1,240,294,000 after purchasing an additional 2,846,560 shares in the last quarter. Finally, APG Asset Management N.V. increased its stake in shares of Procter & Gamble by 1,709.5% in the fourth quarter. APG Asset Management N.V. now owns 2,006,298 shares of the company's stock worth $324,825,000 after purchasing an additional 1,895,421 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the stock. DA Davidson reaffirmed a "buy" rating and issued a $209.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Redburn Atlantic cut Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 target price for the company. in a research report on Thursday. Stifel Nicolaus boosted their price target on Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. UBS Group reiterated a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Finally, Barclays restated an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. One analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $179.80.
Get Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In other news, CEO Gary A. Coombe sold 35,000 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the sale, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at $3,829,817.68. This represents a 61.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the transaction, the chief executive officer now directly owns 51,965 shares of the company's stock, valued at $8,386,111.70. The trade was a 1.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 54,000 shares of company stock valued at $9,330,060 over the last 90 days. Insiders own 0.18% of the company's stock.
Procter & Gamble Stock Down 1.1 %
NYSE:PG traded down $1.87 during mid-day trading on Thursday, hitting $160.70. 2,943,283 shares of the company's stock traded hands, compared to its average volume of 7,143,873. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The company has a market capitalization of $376.82 billion, a P/E ratio of 25.58, a P/E/G ratio of 3.76 and a beta of 0.43. The company has a fifty day moving average of $167.81 and a 200 day moving average of $168.17. The Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. During the same quarter in the prior year, the business posted $1.52 EPS. Procter & Gamble's revenue for the quarter was down 2.1% compared to the same quarter last year. On average, analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.63%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date is Monday, April 21st. Procter & Gamble's payout ratio is presently 66.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report